Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Leukemia

‘End of an Era’: Former Chinese President Jiang Zemin Dies at 96

Former Chinese President Jiang Zemin, who led the country for a decade of rapid economic growth after the Tiananmen crackdown in 1989, died on Wednesday at the age of 96, Chinese state media reported. Jiang died in his home city of Shanghai just after noon on Wednesday of leukemia and…

Asharq Al-Awsat

Former Chinese President Jiang Zemin dies at 96

State media says Jiang died from leukaemia and multiple organ failure in the city of Shanghai.

Al Jazeera

Man vows to give family perfect Christmas as mum-of-six told she has 'days to live'

Ben Gayton is hoping to grant Carrie Dodds-Hallan's wish for a 'perfect Christmas' for her family as she battles Myeloid Leukemia after being told at one point that she may only live a day

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

'This one is for him' - Shamrock Rovers boss Stephen Bradley dedicates emotional title win to his son Josh

The manager's eight-year-old son Josh was diagnosed with leukemia in June but is making good progress

Irish Mirror

India’s Oscar nominated Chhello Show’s child actor Rahul Koli succumbs to leukemia at 10

10-year-old actor Rahul Koli, who played a consequential role in India's Oscar nominated film 'Chhello Show', also called Last Film Show in English, has unfortunately passed away after battling leukemia.

The Times of India

This Cannabis Executive Survived Childhood Leukemia, Now He's Donating $250k To Help Improve Pediatric Cancer Treatment Options

Seeking to help researchers find a new treatment approach for children fighting cancer recurrence, cannabis industry pioneer Joe Caltabiano, co-founder of Cresco Labs (OTC: CRLBF) and founder of JSC Fund, a family office seeking opportunities in regulated markets including cannabis, has made a $250,000 donation to

Benzinga

Hutchinson Dedicates Three-Sack Game to Child With Leukemia

Before the game, he sent a video message to the five-year-old.

Sports Illustrated

Read news from The Economist, FT, and more,
with one subscription

The 10 deadliest cancers, and why there's no cure

The deadliest cancers aren't necessarily the ones that kill the most people overall; they're the ones with the lowest survival rates.

LiveScience

As golf pros flee a hectic industry, leukemia victim Paul Ramee was a case study in happiness

Ramee was successful at balancing the scales between his profession and his home life.

USA Today Sports Media Group

Children Born From Frozen Embryos More Likely To Develop Cancer, Study Finds

Most common forms of the disease were leukemia and those affecting the central nervous system.

Zenger

Former Vols, Bucs Defensive Lineman Steve White Dies at 48

He was diagnosed with chronic lymphocytic leukemia in 2014 and shared in April that he needed to undergo a bone marrow transplant.

Sports Illustrated

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Amgen (NASDAQ:AMGN) announced top-line results from the global Phase 3 CodeBreaK 200 trial evaluating once daily oral LUMAKRAS (sotorasib) in patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC), the study met primary endpoint. Amgen shares traded in a range of $238.29 to $240.31 on day volume of 2.43 million shares, closed regular…

Benzinga

Italian Dad And Japanese Mom Need Special Donor For Child, 2, With Leukemia

The Italian dad and Japanese mom of a two-year-old with a rare kind of leukemia have launched a crowdfunding campaign to find a special donor matching their child’s genetic makeup.

Zenger

Recap Of Friday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangement. Incyte shares traded in a range of $71.38 to $72.98 on day volume of 1.25…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares…

McClatchy Washington Bureau

Camp Lejeune’s water poisoned lives. Decades of fighting finally caused change

Jerry Ensminger sat in the balcony of the U.S. Senate chamber watching a vote that had begun to feel like a pipe dream.

Zenger

Modified Cell Immune Response Key To Defeating Lymphoma, Leukemia

Scientifically-altered T cells, which produce the body’s immune response, may be a key to defeating leukemia, lymphoma, and multiple myeloma, say authors of a new study.

Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant. Eledon shares traded in a range of $2.89 to $3.16 on a day volume of 31.27 thousand…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours:

The Times of India

ISC results: Lucknow girl combats cancer to score 97.75%

LUCKNOW: After 17-year-old Pramita Tewari was diagnosed with Acute Minor Leukemia last year in August, many thought that her future was bleak, but this gritty young girl put up a brave fight. Not only is she on the path of recovery, but also kept her studies going from hospital.

Tribune News Service

Houston Texans rookie John Metchie III diagnosed with leukemia

John Metchie III, the Houston Texans’ 22-year-old wide receiver, has been diagnosed with leukemia and expects to miss the upcoming season, he announced Sunday.

Sports Illustrated

Saban Releases Statement Following Metchie III Leukemia Diagnosis

The Texans rookie receiver starred at Alabama from 2019 to ’21.

USA Today Sports Media Group

Understanding Texans WR John Metchie’s Acute Promyelocytic Leukemia diagnosis

Houston Texans WR John Metchie was diagnosed with Acute Promyelocytic Leukemia, which can be a treatable form of cancer.

USA Today Sports Media Group

Texans show support for WR John Metchie following Acute Promyelocytic Leukemia diagnosis

Receiver John Metchie drew support from past and present Houston Texans following his announcement of his Acute Promyelocytic Leukemia diagnosis.

USA Today Sports Media Group

Twitter reacts to Leukemia diagnosis of Texans rookie WR John Metchie

Houston Texans rookie receiver John Metchie gathered an outpouring of support on Twitter following his diagnosis of Acute Promyelocytic Leukemia.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.